Herpesvirus saimiri-based gene delivery vectors

Rhoswyn A. Griffiths, James R. Boyne, Adrian Whitehouse

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Herpesviruses possess a number of characteristics which make them promising gene delivery vectors. These include their capacity to package large amounts of heterologous DNA and an ability to establish persistent, lifelong infections, where the viral genome remains as a circular non-integrated episome. Herpesvirus saimiri (HVS) is the prototype gamma-2 herpesvirus and is currently being developed as a potential gene delivery vector. In addition to the above properties, HVS-based vectors have the ability to infect a wide range of human cell lines and primary cultures with high efficiencies. Moreover, upon infection the viral genome persists as high copy number, circular, non-integrated episomes which segregate to progeny cells upon division. This allows the HVS-based vector to stably transduce a dividing cell population and provide sustained heterologous gene expression. As such, it offers the characteristics of an artificial chromosome combined with a highly efficient delivery system. This review aims to describe the assessment of HVS-based vectors in both in vitro and in vivo studies, highlighting new developments and possible applications for the treatment of genetic diseases.

Original languageEnglish
Pages (from-to)1-15
Number of pages15
JournalCurrent Gene Therapy
Volume6
Issue number1
DOIs
Publication statusPublished - 1 Feb 2006
Externally publishedYes

Fingerprint

Saimiriine Herpesvirus 2
Viral Genome
Herpesviridae
Genes
Plasmids
Artificial Chromosomes
Inborn Genetic Diseases
Infection
Cell Division
Gene Expression
Cell Line
DNA
Population

Cite this

Griffiths, Rhoswyn A. ; Boyne, James R. ; Whitehouse, Adrian. / Herpesvirus saimiri-based gene delivery vectors. In: Current Gene Therapy. 2006 ; Vol. 6, No. 1. pp. 1-15.
@article{d5db6ed622af4fb1a6eff766f6e51079,
title = "Herpesvirus saimiri-based gene delivery vectors",
abstract = "Herpesviruses possess a number of characteristics which make them promising gene delivery vectors. These include their capacity to package large amounts of heterologous DNA and an ability to establish persistent, lifelong infections, where the viral genome remains as a circular non-integrated episome. Herpesvirus saimiri (HVS) is the prototype gamma-2 herpesvirus and is currently being developed as a potential gene delivery vector. In addition to the above properties, HVS-based vectors have the ability to infect a wide range of human cell lines and primary cultures with high efficiencies. Moreover, upon infection the viral genome persists as high copy number, circular, non-integrated episomes which segregate to progeny cells upon division. This allows the HVS-based vector to stably transduce a dividing cell population and provide sustained heterologous gene expression. As such, it offers the characteristics of an artificial chromosome combined with a highly efficient delivery system. This review aims to describe the assessment of HVS-based vectors in both in vitro and in vivo studies, highlighting new developments and possible applications for the treatment of genetic diseases.",
keywords = "Alpha-herpes virus vectors, EBV-based vectors, Latency-associated nuclear antigen (LANA), Transgene, Tumour xenografts",
author = "Griffiths, {Rhoswyn A.} and Boyne, {James R.} and Adrian Whitehouse",
year = "2006",
month = "2",
day = "1",
doi = "10.2174/156652306775515529",
language = "English",
volume = "6",
pages = "1--15",
journal = "Current Gene Therapy",
issn = "1566-5232",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

Herpesvirus saimiri-based gene delivery vectors. / Griffiths, Rhoswyn A.; Boyne, James R.; Whitehouse, Adrian.

In: Current Gene Therapy, Vol. 6, No. 1, 01.02.2006, p. 1-15.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Herpesvirus saimiri-based gene delivery vectors

AU - Griffiths, Rhoswyn A.

AU - Boyne, James R.

AU - Whitehouse, Adrian

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Herpesviruses possess a number of characteristics which make them promising gene delivery vectors. These include their capacity to package large amounts of heterologous DNA and an ability to establish persistent, lifelong infections, where the viral genome remains as a circular non-integrated episome. Herpesvirus saimiri (HVS) is the prototype gamma-2 herpesvirus and is currently being developed as a potential gene delivery vector. In addition to the above properties, HVS-based vectors have the ability to infect a wide range of human cell lines and primary cultures with high efficiencies. Moreover, upon infection the viral genome persists as high copy number, circular, non-integrated episomes which segregate to progeny cells upon division. This allows the HVS-based vector to stably transduce a dividing cell population and provide sustained heterologous gene expression. As such, it offers the characteristics of an artificial chromosome combined with a highly efficient delivery system. This review aims to describe the assessment of HVS-based vectors in both in vitro and in vivo studies, highlighting new developments and possible applications for the treatment of genetic diseases.

AB - Herpesviruses possess a number of characteristics which make them promising gene delivery vectors. These include their capacity to package large amounts of heterologous DNA and an ability to establish persistent, lifelong infections, where the viral genome remains as a circular non-integrated episome. Herpesvirus saimiri (HVS) is the prototype gamma-2 herpesvirus and is currently being developed as a potential gene delivery vector. In addition to the above properties, HVS-based vectors have the ability to infect a wide range of human cell lines and primary cultures with high efficiencies. Moreover, upon infection the viral genome persists as high copy number, circular, non-integrated episomes which segregate to progeny cells upon division. This allows the HVS-based vector to stably transduce a dividing cell population and provide sustained heterologous gene expression. As such, it offers the characteristics of an artificial chromosome combined with a highly efficient delivery system. This review aims to describe the assessment of HVS-based vectors in both in vitro and in vivo studies, highlighting new developments and possible applications for the treatment of genetic diseases.

KW - Alpha-herpes virus vectors

KW - EBV-based vectors

KW - Latency-associated nuclear antigen (LANA)

KW - Transgene

KW - Tumour xenografts

UR - http://www.scopus.com/inward/record.url?scp=33645735204&partnerID=8YFLogxK

U2 - 10.2174/156652306775515529

DO - 10.2174/156652306775515529

M3 - Review article

VL - 6

SP - 1

EP - 15

JO - Current Gene Therapy

JF - Current Gene Therapy

SN - 1566-5232

IS - 1

ER -